Monitoring of a patient who is on a lipid-lowering drug includes:

Question

Quizplus · Accepted Answer

Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy then again in 6 weeks is the most appropriate for monitoring a patient who is on a lipid-lowering drug. While fasting total cholesterol can be useful, it does not provide information about the specific type of lipids being affected by the medication. Complete blood count, CRP, and ESR are not directly related to lipid-lowering therapy and are not necessary for routine monitoring.

Monitoring of a Patient Who Is on a Lipid-Lowering Drug